Amicus Therapeutics Inc. buy BiotechBee
Start price
13.01.23
/
50%
€11.78
Target price
31.05.24
€17.00
Performance (%)
-9.18%
End price
05.05.23
€10.70
Summary
This prediction ended on 05.05.23 with a price of €10.70. With a performance of -9.18%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -1.190% | -1.190% | -13.089% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Amicus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year